National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

This is VAERS ID 1067086

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 3/19/2021

VAERS ID: 1067086
VAERS Form:2
Age:65.0
Sex:Female
Location:Rhode Island
Vaccinated:2021-01-27
Onset:2021-02-12
Submitted:0000-00-00
Entered:2021-03-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / IM

Administered by: Senior Living      Purchased by: ??
Symptoms: Fatigue, Guillain-Barre syndrome, Muscular weakness, Paraesthesia, Neurological examination, Blood test, Immunoglobulin therapy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? Yes
Hospitalized? Yes, days: 3     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Armour thyroid, Trazedone, QVAR inhaler, Nasonex, melatonin, multi-vitamin, turmeric, vitamin D
Current Illness: none
Preexisting Conditions: hypothyroid
Allergies: NKA
Diagnostic Lab Data: Neurological evaluation and multiple blood tests upon hospitalization 2/15.
CDC 'Split Type':

Write-up: Guillain-Barre Syndrome. 3-day hospitalization, IVIg infusion. Symptoms of tingling feet (started in toes and progressed to whole foot), lower leg weakness and fatigue began 16 days post vaccination. Hospitalization 4 days post symptom onset.


Changed on 5/7/2021

VAERS ID: 1067086 Before After
VAERS Form:2
Age:65.0
Sex:Female
Location:Rhode Island
Vaccinated:2021-01-27
Onset:2021-02-12
Submitted:0000-00-00
Entered:2021-03-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / IM

Administered by: Senior Living      Purchased by: ??
Symptoms: Fatigue, Guillain-Barre syndrome, Muscular weakness, Paraesthesia, Neurological examination, Blood test, Immunoglobulin therapy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? Yes
Hospitalized? Yes, days: 3     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Armour thyroid, Trazedone, QVAR inhaler, Nasonex, melatonin, multi-vitamin, turmeric, vitamin D
Current Illness: none
Preexisting Conditions: hypothyroid
Allergies: NKA NKA
Diagnostic Lab Data: Neurological evaluation and multiple blood tests upon hospitalization 2/15.
CDC 'Split Type':

Write-up: Guillain-Barre Syndrome. 3-day hospitalization, IVIg infusion. Symptoms of tingling feet (started in toes and progressed to whole foot), lower leg weakness and fatigue began 16 days post vaccination. Hospitalization 4 days post symptom onset.


Changed on 5/21/2021

VAERS ID: 1067086 Before After
VAERS Form:2
Age:65.0
Sex:Female
Location:Rhode Island
Vaccinated:2021-01-27
Onset:2021-02-12
Submitted:0000-00-00
Entered:2021-03-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / IM

Administered by: Senior Living      Purchased by: ??
Symptoms: Fatigue, Guillain-Barre syndrome, Muscular weakness, Paraesthesia, Neurological examination, Blood test, Immunoglobulin therapy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? Yes
Hospitalized? Yes, days: 3     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Armour thyroid, Trazedone, QVAR inhaler, Nasonex, melatonin, multi-vitamin, turmeric, vitamin D
Current Illness: none
Preexisting Conditions: hypothyroid
Allergies: NKA NKA
Diagnostic Lab Data: Neurological evaluation and multiple blood tests upon hospitalization 2/15.
CDC 'Split Type':

Write-up: Guillain-Barre Syndrome. 3-day hospitalization, IVIg infusion. Symptoms of tingling feet (started in toes and progressed to whole foot), lower leg weakness and fatigue began 16 days post vaccination. Hospitalization 4 days post symptom onset.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1067086&WAYBACKHISTORY=ON


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166